Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1494891 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.85Day −3.06%Mkt cap $47M1Y −46.5%Off 52W high −51.9%Vol (1Y) 74.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,511 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.2% of sh out |
| Days to cover8.5d |
| 13F net flow (QoQ)+0.07% |
| Top-10 13F concentration79.5% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$22.5M |
| Earnings (TTM)-$7.8M |
| ROE−14.9% |
| Net margin−28.1% |
| ROIC−27.2% |
| Sales growth 3Y−14.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−28.4% |
| 1Y−46.5% |
| 3Y−5.0% |
| 5Y−21.9% |
| 10Y−53.4% |
| Since incept. (ann.)−6.9% |
Total return through 2026-07-29 · series begins 2016-07-26. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)74.2% |
| Ann. volatility (3Y)76.4% |
| Sharpe (1Y)−0.46 |
| Sharpe (3Y)0.38 |
| Max drawdown (1Y)−51.9% |
| Max drawdown (3Y)−70.1% |
| Beta (3Y vs SPY)1.59 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Pacific Ridge Capital Partners, LLC | 796,072 | $3M | 4.84% | +13.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 648,225 | $3M | 3.94% | new |
| DIMENSIONAL FUND ADVISORS LP | 387,392 | $2M | 2.35% | −12.7% |
| Divisadero Street Capital Management, LP | 286,078 | $1M | 1.74% | −4.3% |
| RENAISSANCE TECHNOLOGIES LLC | 252,234 | $1M | 1.53% | −1.9% |
| UBS Group AG | 172,870 | $688,023 | 1.05% | +27.3% |
| GEODE CAPITAL MANAGEMENT, LLC | 165,550 | $659,032 | 1.01% | +4.6% |
| Meros Investment Management, LP | 152,418 | $606,624 | 0.93% | −2.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.16 | — | $3.4M | −59.3% |
| 2025-12-31 | 2026-02-12 | — | — | $4.9M | −62.2% |
| 2025-09-30 | 2025-11-06 | −$0.06 | −185.7% | $6.9M | −22.1% |
| 2025-06-30 | 2025-08-07 | −$0.06 | −160.0% | $7.3M | −20.8% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
US 92% · CN 7% · Other 0%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
